A study published in JAMA Ophthalmology has identified a potential link between popular weight-loss medications and severe, sometimes permanent, vision complications. The small-scale study evaluated nine patients who experienced acute vision issues while taking semaglutide medications, such as Ozemp ic and Wegovy, or tirzepatide drugs, including Mounjaro and Zepbound. Among the participants, seven developed non-arteritic ischemic […] Rare GLP-1 Vision Loss Risks Fuel Growing Gray Market Supply Chain Concerns ...read more read less